Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Fetal Membranes, Premature Rupture D005322 4 associated lipids
Fatty Liver D005234 48 associated lipids
Eyelid Diseases D005141 4 associated lipids
Eye Diseases D005128 12 associated lipids
Exanthema D005076 11 associated lipids
Escherichia coli Infections D004927 17 associated lipids
Erythema Nodosum D004893 5 associated lipids
Epiglottitis D004826 1 associated lipids
Enteritis D004751 8 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Elephantiasis, Filarial D004605 4 associated lipids
Elephantiasis D004604 2 associated lipids
Eisenmenger Complex D004541 1 associated lipids
Edema D004487 152 associated lipids
Ectodermal Dysplasia D004476 1 associated lipids
Dyspnea D004417 10 associated lipids
Dysentery, Bacillary D004405 6 associated lipids
Dry Socket D004368 3 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Dog Diseases D004283 5 associated lipids
Digestive System Diseases D004066 3 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Drug Eruptions D003875 30 associated lipids
Cytomegalovirus Infections D003586 7 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Cryptosporidiosis D003457 3 associated lipids
Cross Infection D003428 9 associated lipids
Crohn Disease D003424 12 associated lipids
Corynebacterium Infections D003354 7 associated lipids
Coronary Disease D003327 70 associated lipids
Corneal Opacity D003318 3 associated lipids
Conjunctivitis, Inclusion D003235 4 associated lipids
Conjunctivitis, Bacterial D003234 3 associated lipids
Colitis D003092 69 associated lipids
Ciliary Motility Disorders D002925 2 associated lipids
Chronic Disease D002908 7 associated lipids
Chlamydiaceae Infections D002694 2 associated lipids
Chlamydia Infections D002690 7 associated lipids
Chancroid D002602 4 associated lipids
Uterine Cervicitis D002575 3 associated lipids
Cat-Scratch Disease D002372 4 associated lipids
Cat Diseases D002371 12 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Carcinoma, Basal Cell D002280 6 associated lipids
Burns D002056 34 associated lipids
Bronchiolitis Obliterans D001989 8 associated lipids
Bronchiolitis D001988 6 associated lipids
Boutonneuse Fever D001907 5 associated lipids
Body Weight D001835 333 associated lipids
Blister D001768 16 associated lipids
Bites, Human D001734 2 associated lipids
Birth Weight D001724 23 associated lipids
Bartonella Infections D001474 3 associated lipids
Bacterial Infections D001424 21 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Arthritis D001168 41 associated lipids
Arteriosclerosis D001161 86 associated lipids
Aphasia, Broca D001039 1 associated lipids
Angina, Unstable D000789 14 associated lipids
Anaplasmataceae Infections D000711 3 associated lipids
Anaphylaxis D000707 35 associated lipids
Amebiasis D000562 2 associated lipids
Airway Obstruction D000402 13 associated lipids
Agammaglobulinemia D000361 4 associated lipids
Actinomycetales Infections D000193 4 associated lipids
Acquired Immunodeficiency Syndrome D000163 12 associated lipids
Acne Vulgaris D000152 35 associated lipids
Acinetobacter Infections D000151 4 associated lipids
Achondroplasia D000130 1 associated lipids
Abscess D000038 13 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Abnormalities, Drug-Induced D000014 10 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
Lakew T et al. Reduction and return of infectious trachoma in severely affected communities in Ethiopia. 2009 PLoS Negl Trop Dis pmid:19190781
Coulibaly YI et al. A cluster randomized study of the safety of integrated treatment of trachoma and lymphatic filariasis in children and adults in Sikasso, Mali. 2013 PLoS Negl Trop Dis pmid:23675549
King JD et al. Prevalence of trachoma at sub-district level in ethiopia: determining when to stop mass azithromycin distribution. 2014 PLoS Negl Trop Dis pmid:24625539
Ray KJ et al. When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries. 2009 PLoS Negl Trop Dis pmid:19529761
Amza A et al. Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trial. 2012 PLoS Negl Trop Dis pmid:22545165
Vlieghe ER et al. Azithromycin and ciprofloxacin resistance in Salmonella bloodstream infections in Cambodian adults. 2012 PLoS Negl Trop Dis pmid:23272255
Speer EM et al. Pentoxifylline, dexamethasone and azithromycin demonstrate distinct age-dependent and synergistic inhibition of TLR- and inflammasome-mediated cytokine production in human newborn and adult blood in vitro. 2018 PLoS ONE pmid:29715306
Laufer MK et al. A longitudinal trial comparing chloroquine as monotherapy or in combination with artesunate, azithromycin or atovaquone-proguanil to treat malaria. 2012 PLoS ONE pmid:22912697
Liu D et al. Mycoplasma-associated multidrug resistance of hepatocarcinoma cells requires the interaction of P37 and Annexin A2. 2017 PLoS ONE pmid:28976984
Lee S et al. The therapeutic efficacy of azithromycin and nitazoxanide in the acute pig model of Cryptosporidium hominis. 2017 PLoS ONE pmid:28973041
Mandhane PJ et al. Treatment of preschool children presenting to the emergency department with wheeze with azithromycin: A placebo-controlled randomized trial. 2017 PLoS ONE pmid:28771627
Upadhyay K et al. Combination therapy with ampicillin and azithromycin improved outcomes in a mouse model of group B streptococcal sepsis. 2017 PLoS ONE pmid:28759625
Li R et al. Effects of oral florfenicol and azithromycin on gut microbiota and adipogenesis in mice. 2017 PLoS ONE pmid:28742883
West SK et al. Treating village newcomers and travelers for trachoma: Results from ASANTE cluster randomized trial. 2017 PLoS ONE pmid:28662043
Vodstrcil LA et al. Measurement of tissue azithromycin levels in self-collected vaginal swabs post treatment using liquid chromatography and tandem mass spectrometry (LC-MS/MS). 2017 PLoS ONE pmid:28498845
Amran MY et al. Investigation of encephalopathy caused by Shiga toxin 2c-producing Escherichia coli infection in mice. 2013 PLoS ONE pmid:23516588
Vandooren J et al. Differential inhibition of activity, activation and gene expression of MMP-9 in THP-1 cells by azithromycin and minocycline versus bortezomib: A comparative study. 2017 PLoS ONE pmid:28369077
Kong FY et al. Pharmacokinetics of a single 1g dose of azithromycin in rectal tissue in men. 2017 PLoS ONE pmid:28350806
Ishiguro N et al. Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients. 2017 PLoS ONE pmid:28288170
Simpson JL et al. The effect of azithromycin in adults with stable neutrophilic COPD: a double blind randomised, placebo controlled trial. 2014 PLoS ONE pmid:25148049
Dukers-Muijrers NH et al. Chlamydia trachomatis test-of-cure cannot be based on a single highly sensitive laboratory test taken at least 3 weeks after treatment. 2012 PLoS ONE pmid:22470526
Hirasawa K et al. Macrolide Antibiotics Exhibit Cytotoxic Effect under Amino Acid-Depleted Culture Condition by Blocking Autophagy Flux in Head and Neck Squamous Cell Carcinoma Cell Lines. 2016 PLoS ONE pmid:27977675
Zhao X et al. Sensitive and Simplified Detection of Antibiotic Influence on the Dynamic and Versatile Changes of Fecal Short-Chain Fatty Acids. 2016 PLoS ONE pmid:27907030
Nielsen HL et al. Azithromycin vs. Placebo for the Clinical Outcome in Campylobacter concisus Diarrhoea in Adults: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. 2016 PLoS ONE pmid:27893820
Phiri K et al. Parasitological Clearance Rates and Drug Concentrations of a Fixed Dose Combination of Azithromycin-Chloroquine in Asymptomatic Pregnant Women with Plasmodium Falciparum Parasitemia: An Open-Label, Non-Comparative Study in Sub-Saharan Africa. 2016 PLoS ONE pmid:27861509
Kalilani L et al. A randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant women. 2007 PLoS ONE pmid:18000538
Bradshaw CS et al. Persistence of Mycoplasma genitalium following azithromycin therapy. 2008 PLoS ONE pmid:18978939
Cui W et al. The molecular mechanism of action of the CR6261-Azichromycin combination found through computational analysis. 2012 PLoS ONE pmid:22693576
Matheson AI et al. Prioritizing countries for interventions to reduce child mortality: tools for maximizing the impact of mass drug administration of azithromycin. 2014 PLoS ONE pmid:24837459
Tong ML et al. Factors associated with serological cure and the serofast state of HIV-negative patients with primary, secondary, latent, and tertiary syphilis. 2013 PLoS ONE pmid:23894598
Assani K et al. IFN-γ stimulates autophagy-mediated clearance of Burkholderia cenocepacia in human cystic fibrosis macrophages. 2014 PLoS ONE pmid:24798083
Zhu B et al. High Resistance to Azithromycin in Clinical Samples from Patients with Sexually Transmitted Diseases in Guangxi Zhuang Autonomous Region, China. 2016 PLoS ONE pmid:27467164
Goh YS et al. Neutralizing Antibodies against Plasmodium falciparum Associated with Successful Cure after Drug Therapy. 2016 PLoS ONE pmid:27427762
Malhotra S et al. Prevalence of Trachoma in Car-Nicobar Island, India after Three Annual Rounds of Mass Drug Administration with Azithromycin. 2016 PLoS ONE pmid:27391274
Kakeya H et al. Efficacy of combination therapy with oseltamivir phosphate and azithromycin for influenza: a multicenter, open-label, randomized study. 2014 PLoS ONE pmid:24632748
Kimani J et al. Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An Open-Label, Randomized Trial. 2016 PLoS ONE pmid:27326859
Dukers-Muijrers NH et al. Detection of anorectal and cervicovaginal Chlamydia trachomatis infections following azithromycin treatment: prospective cohort study with multiple time-sequential measures of rRNA, DNA, quantitative load and symptoms. 2013 PLoS ONE pmid:24278400
Haussig JM et al. Experimental Genetics of Plasmodium berghei NFU in the Apicoplast Iron-Sulfur Cluster Biogenesis Pathway. 2013 PLoS ONE pmid:23805304
McCallum GB et al. A single dose of azithromycin does not improve clinical outcomes of children hospitalised with bronchiolitis: a randomised, placebo-controlled trial. 2013 PLoS ONE pmid:24086334
Luntamo M et al. The effect of monthly sulfadoxine-pyrimethamine, alone or with azithromycin, on PCR-diagnosed malaria at delivery: a randomized controlled trial. 2012 PLoS ONE pmid:22829919
Zhou T et al. Fabrication of a Selective and Sensitive Sensor Based on Molecularly Imprinted Polymer/Acetylene Black for the Determination of Azithromycin in Pharmaceuticals and Biological Samples. 2016 PLoS ONE pmid:26820753
Swatton JE et al. Impact of Azithromycin on the Quorum Sensing-Controlled Proteome of Pseudomonas aeruginosa. 2016 PLoS ONE pmid:26808156
Slade J et al. Chlamydial Pre-Infection Protects from Subsequent Herpes Simplex Virus-2 Challenge in a Murine Vaginal Super-Infection Model. 2016 PLoS ONE pmid:26726882
Al-Darraji A et al. Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: Potential therapeutic targets in ischemic heart disease. 2018 PLoS ONE pmid:30001416
Coloma PM et al. Drug-induced acute myocardial infarction: identifying 'prime suspects' from electronic healthcare records-based surveillance system. 2013 PLoS ONE pmid:24015213
Dolecek C et al. A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. 2008 PLoS ONE pmid:18493312
Yang D et al. The timing of azithromycin treatment is not associated with the clinical prognosis of childhood Mycoplasma pneumoniae pneumonia in high macrolide-resistant prevalence settings. 2018 PLoS ONE pmid:29377957
Wacker K et al. Short-term azithromycin treatment promotes cornea allograft survival in the rat. 2013 PLoS ONE pmid:24349336
Wei HX et al. A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans. 2015 PLoS ONE pmid:26394212
Ribeiro CM et al. Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia. 2009 PLoS ONE pmid:19503797
Anagrius C et al. Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic. 2013 PLoS ONE pmid:23593483
Hahn DL et al. Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity. 2012 PLoS ONE pmid:22545149
Banerjee B et al. Regional differences in susceptibiity of bronchial epithelium to mesenchymal transition and inhibition by the macrolide antibiotic azithromycin. 2012 PLoS ONE pmid:23284981
Kaman WE et al. Evaluation of a FRET-peptide substrate to predict virulence in Pseudomonas aeruginosa. 2013 PLoS ONE pmid:24303047
Twin J et al. Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysis. 2012 PLoS ONE pmid:22532861
Maher MC et al. The fitness cost of antibiotic resistance in Streptococcus pneumoniae: insight from the field. 2012 PLoS ONE pmid:22272234
Prohl A et al. Enrofloxacin and macrolides alone or in combination with rifampicin as antimicrobial treatment in a bovine model of acute Chlamydia psittaci infection. 2015 PLoS ONE pmid:25768665
Hao K et al. The pharmacokinetic-pharmacodynamic model of azithromycin for lipopolysaccharide-induced depressive-like behavior in mice. 2013 PLoS ONE pmid:23358536
Köhler T et al. Quorum sensing inhibition selects for virulence and cooperation in Pseudomonas aeruginosa. 2010 PLoS Pathog. pmid:20463812
Handrick W et al. [Pulmonary infection due to Mycobacterium malmoense]. 2005 Pneumologie pmid:15944898
Aktan B et al. Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion. 2003 Nov-Dec Pol J Pharmacol pmid:14730107
Zygner W et al. Azithromycin in the treatment of a dog infected with Giardia intestinalis. 2008 Pol J Vet Sci pmid:18942546
Mammen MJ and Sethi S Macrolide therapy for the prevention of acute exacerbations in chronic obstructive pulmonary disease. 2012 Pol. Arch. Med. Wewn. pmid:22353707
Faber M et al. [Evaluation of clinical effectiveness and direct costs of azithromycin treatment for exacerbation of chronic obstructive pulmonary disease in hospitalized patients and ambulatory care]. 2004 Pol. Merkur. Lekarski pmid:15524029
Breborowicz A [Azithromycin in the therapy of lower respiratory tract infection in children]. 2008 Pol. Merkur. Lekarski pmid:19177779
Breborowicz A [Antibiotic therapy in asthma exacerbation and in cystic fibrosis in children]. 2011 Pol. Merkur. Lekarski pmid:21675140
Faber M et al. [Comparative analysis of the effectiveness and costs of azithromycin and cefoperazone treatment of patients during COPD exacerbation]. 2003 Pol. Merkur. Lekarski pmid:12712826
Rifabutin for MAC questioned. 1995 Jul-Aug Posit Aware pmid:11362571
D'Amico R ICAAC update on opportunistic infections. 1996 Nov-Dec Posit Aware pmid:11363974
Eagan L Data on HIV infection in women expands. 1999 Posit Living pmid:11367336
Cramer CL et al. Immunomodulatory indications of azithromycin in respiratory disease: a concise review for the clinician. 2017 Postgrad Med pmid:28116959
Barlam TF Expedited treatment for partners of patients with gonorrhea and/or chlamydial infection: impact on rates of persistence or recurrence. 2005 Postgrad Med pmid:15948359
Rapp RP Clinical and economic outcomes in respiratory tract infections: The impact of bacterial resistance. 2002 Postgrad Med pmid:19667590
Miedinger D [Dysuria and urethral discharge after travel abroad]. 2006 Praxis (Bern 1994) pmid:16640179
Steurer J [In Process Citation]. 2013 Praxis (Bern 1994) pmid:23919943
Ryser C and Hasler P [[Reactive arthritis]. 2010 Praxis (Bern 1994) pmid:21049437
Pollock E and Hasse B [CME. Pertussis]]. 2015 Praxis (Bern 1994) pmid:26331198
Lanz J and Lautenschlager S [CME Dermatology 16/Answer: Fever, Pustules and Joint Pain as Vacation Mementoes]. 2018 Praxis (Bern 1994) pmid:29921188
Steurer J [Azithromycin in the treatment of pneumonia in the elderly is not dangerous]. 2014 Praxis (Bern 1994) pmid:25228579
Gramellini D et al. Mid-trimester amniocentesis and antibiotic prophylaxis. 2007 Prenat. Diagn. pmid:17607664
Giorlandino C et al. Antibiotic prophylaxis before second-trimester genetic amniocentesis (APGA): a single-centre open randomised controlled trial. 2009 Prenat. Diagn. pmid:19294678
Yaws, a non-venereal treponemal infection. Still endemic in some parts of the world. 2012 Prescrire Int pmid:23016260
Antibiotic therapy for trachoma. 2009 Prescrire Int pmid:19750586
Intrauterine devices: antibiotic prophylaxis not necessary during insertion. 2001 Prescrire Int pmid:11718174
Azithromycin: cardiovascular deaths. 2013 Prescrire Int pmid:23383407
de Barbeyrac B [Current aspects of Chlamydia trachomatis infection]. 2013 Presse Med pmid:23419460
Chanal J et al. [What's new in the diagnosis and treatment of Neisseria gonorrhoeae]. 2013 Presse Med pmid:23433914
James GD et al. Use of long-term antibiotic treatment in COPD patients in the UK: a retrospective cohort study. 2013 Prim Care Respir J pmid:23839240
Palmer NO Pharmaceutical prescribing for children. Part 3. Antibiotic prescribing for children with odontogenic infections. 2006 Prim Dent Care pmid:16393495
Bulkley D et al. Revisiting the structures of several antibiotics bound to the bacterial ribosome. 2010 Proc. Natl. Acad. Sci. U.S.A. pmid:20876130
Davis AR et al. Sequence selectivity of macrolide-induced translational attenuation. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:25313041
Retallack H et al. Zika virus cell tropism in the developing human brain and inhibition by azithromycin. 2016 Proc. Natl. Acad. Sci. U.S.A. pmid:27911847
Bakheit AH et al. Azithromycin. 2014 Profiles Drug Subst Excip Relat Methodol pmid:24794904
Hanssens L et al. The clinical benefits of long-term supplementation with omega-3 fatty acids in cystic fibrosis patients - A pilot study. 2016 Prostaglandins Leukot. Essent. Fatty Acids pmid:27154364
Szpakowski M and Szawłowski A [Azithromycin (Sumamed) administration in empiric treatment of nosocomial pneumonia in upper digestive tract cancer patients]. 2003 Prz. Lek. pmid:14575010
Serwin AB et al. Gonorrhoea in 21st century--international and Polish situation. 2014 Przegl Epidemiol pmid:25004630
Biernat-Sudolska M et al. [Voice on the treatment of ureaplasmas infections]. 2009 Przegl Epidemiol pmid:19522233
Weinschenk K and Schwartz AC A case report of closed-eye visual hallucinations. 2011 Jan-Feb Psychosomatics pmid:21300201
Sharpton R et al. Do cystic fibrosis patients on azithromycin need electrocardiogram monitoring? 2017 Pulm Pharmacol Ther pmid:28219728
Morinaga Y et al. Azithromycin, clarithromycin and telithromycin inhibit MUC5AC induction by Chlamydophila pneumoniae in airway epithelial cells. 2009 Pulm Pharmacol Ther pmid:19716898